Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Biochem Biophys ; 2001 Feb-Apr; 38(1-2): 64-70
Article Dans Anglais | IMSEAR | ID: sea-29122

Résumé

Anti-cancer antibiotics, chromomycin A3 (CHR) and mithramycin (MTR) inhibit DNA directed RNA synthesis in vivo by binding reversibly to template DNA in the minor groove with GC base specificity, in the presence of divalent cations like Mg2+. Under physiological conditions, (drug)2Mg2+ complexes formed by the antibiotics are the potential DNA binding ligands. Structures of CHR and MTR differ in their saccharide residues. Scrutiny of the DNA binding properties reveal significant differences in their sequence selectivity, orientation and stoichiometry of binding. Here, we have analyzed binding and thermodynamic parameters for the interaction of the antibiotics with a model oligonucleotide sequence, d(TAGCTAGCTA)2 to understand the role of sugars. The oligomer contains two potential binding sites (GpC) for the ligands. The study illustrates that the drugs bind differently to the sequence. (MTR)2Mg2+ binds to both sites whereas (CHR)2Mg2+ binds to a single site. UV melting profiles for the decanucleotide saturated with the ligands show that MTR bound oligomer is highly stabilized and melts symmetrically. In contrast, with CHR, loss of symmetry in the oligomer following its association with a single (CHR)2Mg2+ complex molecule leads to a biphasic melting curve. Results have been interpreted in the light of saccharide dependent differences in ligand flexibility between the two antibiotics.


Sujets)
Sites de fixation , Chromomycine A3/composition chimique , ADN/métabolisme , Cinétique , Ligands , Magnésium/pharmacologie , Modèles chimiques , Conformation d'acide nucléique , Inhibiteurs de la synthèse d'acide nucléique/composition chimique , Mithramycine/composition chimique , Liaison aux protéines , ARN/métabolisme , Spectrophotométrie , Température , Thermodynamique , Rayons ultraviolets
2.
Indian J Biochem Biophys ; 2001 Feb-Apr; 38(1-2): 71-4
Article Dans Anglais | IMSEAR | ID: sea-26445

Résumé

Mithramycin (MTR) is an anti-cancer antibiotic that blocks the macromolecular biosynthesis via reversible interaction with DNA template in the presence of bivalent metal ion such as Mg2+. In absence of DNA, mithramycin forms two types of complexes with Mg2+, complex I (with 1:1 stoichiometry in terms of MTR: Mg2+) and complex II (with 1:2 stoichiometry in terms of MTR: Mg2+). In an eukaryotic system, the drug would interact with chromatin, a protein-DNA complex. We have employed the spectroscopic techniques such as absorption and fluorescence to study the interaction of MTR: Mg2+ complexes with rat liver chromatin. In this report, we have shown that the two types of ligands have different binding potentials with the same chromatin. This supports our proposition that complexes I and II, are different molecular species. We have also shown that the histone protein(s) reduce the binding potential and the number of available sites for both ligands.


Sujets)
Animaux , Chromatine/composition chimique , Relation dose-effet des médicaments , Histone/composition chimique , Cinétique , Ligands , Foie/métabolisme , Magnésium/métabolisme , Mâle , Inhibiteurs de la synthèse d'acide nucléique/composition chimique , Mithramycine/composition chimique , Liaison aux protéines , Rats , Spectrométrie de fluorescence
SÉLECTION CITATIONS
Détails de la recherche